Latest News About Mpox

Here’s the latest on mpox (Monkeypox) as of now:

• Global situation and WHO status

  • The World Health Organization has maintained mpox as an area of ongoing concern in several regions, with heightened emphasis on surveillance, vaccination strategies, and rapid diagnostics in outbreak settings. This reflects continued attention since the 2023–2024 surge and subsequent containment efforts.[2]

• Outbreak dynamics and regional activity

  • Mpox activity remains variable by region, with sporadic cases reported in different countries and ongoing efforts to prevent cross-border transmission through screening, testing, and contact tracing. Health agencies continue to monitor potential shifts in transmission patterns, including any changing clade distributions or case demographics.[3][2]

• Vaccines, therapeutics, and preparedness

  • European and other regional health authorities have pursued procurement and deployment plans for mpox vaccines (e.g., MVA-BN) to bolster preparedness and outbreak response capacity, alongside exploration of booster strategies and targeted vaccination campaigns. Antiviral development continues, with attention to drugs targeting mpox and related orthopoxviruses as part of broader pandemic readiness.[1][2]

• Public health guidance

  • Countries are advised to maintain robust mpox surveillance, ensure access to diagnostics capable of detecting mpox clades, and reinforce infection prevention controls in healthcare and community settings. Public awareness and risk communication remain key components of the response.[2]

If you’d like, I can narrow this to a specific region (e.g., United States, Europe, or Africa), or pull the most recent briefings from a major health organization for a precise date. I can also provide a quick one-page summary suitable for sharing with others.